• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明尼苏达州奥尔姆斯特德县1935年至1989年慢性淋巴细胞白血病的发病率,重点关注诊断时初始阶段的变化。

Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis.

作者信息

Call T G, Phyliky R L, Noël P, Habermann T M, Beard C M, O'Fallon W M, Kurland L T

机构信息

Division of Hematology and Internal Medicine, Mayo Clinic Rochester, Minnesota 55905.

出版信息

Mayo Clin Proc. 1994 Apr;69(4):323-8. doi: 10.1016/s0025-6196(12)62215-0.

DOI:10.1016/s0025-6196(12)62215-0
PMID:8170175
Abstract

OBJECTIVE

To determine whether the stage at the time of diagnosis of chronic lymphocytic leukemia (CLL) had changed during a 55-year period.

DESIGN

We conducted a study of the cohort of residents of Olmsted County, Minnesota, who had been diagnosed as having CLL during the period from 1935 through 1989.

MATERIAL AND METHODS

By analysis of medical records, patients with CLL were characterized by Rai stage, absolute lymphocyte count, age at diagnosis, need for therapy, and reported cause of death in nonsurvivors. Trends for these variables were analyzed by decade throughout the study period.

RESULTS

The overall annual incidence rate of CLL per 100,000 population in Olmsted County increased from 2.6 in the 1935 through 1944 period to 5.4 in the 1975 through 1984 period; however, the increasing rate was found only for those 50 years of age or older and was especially dramatic for those 75 years old or older. Analysis of Rai stage over time demonstrated an increase in the proportion of cases diagnosed as Rai stage 0. In addition, the median absolute lymphocyte count decreased, the median time to initiation of therapy increased, and the median age of patients with Rai stage 0 CLL at the time of diagnosis increased over time. Overall, 54% of patients had received therapy for CLL by the time of last follow-up. Among the nonsurvivors, CLL was documented as the underlying or a contributing cause of death in 69%.

CONCLUSION

The overall increase in CLL was thought to be due to enhanced methods of early diagnosis and improved health care for the elderly population. Thus, artifact may best explain the observed trend, although we cannot exclude the possibility of an actual increase in incidence rates over time.

摘要

目的

确定慢性淋巴细胞白血病(CLL)诊断时的分期在55年期间是否发生了变化。

设计

我们对明尼苏达州奥尔姆斯特德县在1935年至1989年期间被诊断为患有CLL的居民队列进行了研究。

材料与方法

通过分析病历,以Rai分期、绝对淋巴细胞计数、诊断时年龄、治疗需求以及非存活者报告的死亡原因对CLL患者进行特征描述。在整个研究期间按十年分析这些变量的趋势。

结果

奥尔姆斯特德县每10万人口中CLL的总体年发病率从1935年至该年期间的2.6上升至1975年至1984年期间的5.4;然而,发病率增加仅见于50岁及以上人群,对于75岁及以上人群尤为显著。对Rai分期随时间的分析显示,诊断为Rai 0期的病例比例增加。此外,绝对淋巴细胞计数中位数下降,开始治疗的中位时间增加,且诊断时Rai 0期CLL患者的中位年龄随时间增加。总体而言,到最后一次随访时,54%的患者接受了CLL治疗。在非存活者中,69%记录CLL为潜在或促成死亡的原因。

结论

CLL的总体增加被认为是由于早期诊断方法的改进和老年人群医疗保健的改善。因此,尽管我们不能排除发病率随时间实际增加的可能性,但人为因素可能最能解释观察到的趋势。

相似文献

1
Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis.明尼苏达州奥尔姆斯特德县1935年至1989年慢性淋巴细胞白血病的发病率,重点关注诊断时初始阶段的变化。
Mayo Clin Proc. 1994 Apr;69(4):323-8. doi: 10.1016/s0025-6196(12)62215-0.
2
Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.采用2008年指南诊断慢性淋巴细胞白血病和高计数单克隆B细胞淋巴细胞增多症的发病率
Cancer. 2014 Jul 1;120(13):2000-5. doi: 10.1002/cncr.28690. Epub 2014 Apr 7.
3
Incidence of leukemia in Olmsted County, Minnesota, 1975 through 1989.明尼苏达州奥姆斯特德县1975年至1989年白血病发病率。
Mayo Clin Proc. 1994 Apr;69(4):315-22. doi: 10.1016/s0025-6196(12)62214-9.
4
Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines.采用2008年慢性淋巴细胞白血病国际研讨会指南后早期慢性淋巴细胞白血病患者的发病率、临床表现模式及临床结局的变化
Expert Rev Hematol. 2014 Oct;7(5):691-5. doi: 10.1586/17474086.2014.954542. Epub 2014 Aug 31.
5
Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者中晚期白血病和皮肤癌肿瘤分期与皮肤癌不良预后相关。
JAMA Dermatol. 2014 Mar;150(3):280-7. doi: 10.1001/jamadermatol.2013.6249.
6
[Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].[2003年至2013年冰岛的慢性淋巴细胞白血病:发病率、临床表现及诊断]
Laeknabladid. 2016 Apr;102(4):171-7. doi: 10.17992/lbl.2016.04.74.
7
Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China?中国是否存在慢性淋巴细胞白血病(CLL)的流行情况?
Leuk Res. 2018 Oct;73:16-20. doi: 10.1016/j.leukres.2018.08.011. Epub 2018 Aug 22.
8
Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.年轻成人早期/中期慢性淋巴细胞白血病(B-CLL)的预后特征与生存情况:一项单机构研究
Leukemia. 1993 Aug;7(8):1232-5.
9
Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD).慢性淋巴细胞白血病患者的发病率及医疗资源利用趋势:来自英国临床实践研究数据链(CPRD)的见解
Ann Hematol. 2015 Mar;94(3):421-9. doi: 10.1007/s00277-014-2217-7. Epub 2014 Sep 16.
10
Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.慢性淋巴细胞白血病常规血涂片上涂抹细胞百分比的预后及预测意义
Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):514-7. doi: 10.1016/j.clml.2014.02.007. Epub 2014 Feb 18.

引用本文的文献

1
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?GWAS 鉴定的慢性淋巴细胞白血病风险变异是否影响患者总体生存和疾病进展?
Int J Mol Sci. 2023 Apr 28;24(9):8005. doi: 10.3390/ijms24098005.
2
Concomitant Essential Thrombocythemia and Mature B -Lymphoproliferative Disorder in a Patient.一名患者同时患有原发性血小板增多症和成熟B淋巴细胞增殖性疾病。
Int J Hematol Oncol Stem Cell Res. 2021 Oct 1;15(4):255-259. doi: 10.18502/ijhoscr.v15i4.7481.
3
Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.
Venetoclax-Obinutuzumab 治疗初治及复发/难治性慢性淋巴细胞白血病的 1b 期临床研究。
Blood. 2019 Jun 27;133(26):2765-2775. doi: 10.1182/blood-2019-01-896290. Epub 2019 Mar 12.
4
Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.高计数MBL病例的基因组特征表明,驱动突变的早期检测和亚克隆扩增是不良临床结局的预测指标。
Leukemia. 2017 Jan;31(1):170-176. doi: 10.1038/leu.2016.172. Epub 2016 Jun 14.
5
Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.探索血液系统恶性肿瘤中的大数据:挑战与机遇
Curr Hematol Malig Rep. 2016 Aug;11(4):271-9. doi: 10.1007/s11899-016-0331-4.
6
Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics.同时诊断的慢性淋巴细胞白血病和骨髓增殖性肿瘤:临床和生物学特征
Leuk Lymphoma. 2016 May;57(5):1054-9. doi: 10.3109/10428194.2015.1092527. Epub 2015 Oct 19.
7
Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis.高计数单克隆B细胞淋巴细胞增多症患者发生非血液系统癌症的风险。
Leukemia. 2016 Feb;30(2):331-6. doi: 10.1038/leu.2015.235. Epub 2015 Aug 27.
8
Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia.深度测序揭示慢性淋巴细胞白血病中的基因异质性和复发性趋同进化。
Blood. 2015 Jan 15;125(3):492-8. doi: 10.1182/blood-2014-06-580563. Epub 2014 Nov 6.
9
Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的病史、生活方式、家族史及职业风险因素:国际淋巴瘤非霍奇金淋巴瘤亚型研究项目
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):41-51. doi: 10.1093/jncimonographs/lgu001.
10
Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.采用2008年指南诊断慢性淋巴细胞白血病和高计数单克隆B细胞淋巴细胞增多症的发病率
Cancer. 2014 Jul 1;120(13):2000-5. doi: 10.1002/cncr.28690. Epub 2014 Apr 7.